Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis - PubMed (original) (raw)
Review
. 2008 Apr 30;41(4):278-86.
doi: 10.5483/bmbrep.2008.41.4.278.
Affiliations
- PMID: 18452647
- DOI: 10.5483/bmbrep.2008.41.4.278
Free article
Review
Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis
Masabumi Shibuya. BMB Rep. 2008.
Free article
Abstract
Angiogenesis, the formation of blood vessels, is essential for preparing a closed circulatory system in the body, and for supplying oxygen and nutrition to tissues. Major diseases such as cancer, rheumatoid arthritis, and atherosclerosis include pathological angiogenesis in their malignant processes, suggesting anti-angiogenic therapy to be a new strategy for suppression of diseases. However, until the 1970s, the molecular basis of angiogenesis was largely unknown. In recent decades, extensive studies have revealed a variety of angiogenic factors and their receptors, including vascular endothelial growth factor (VEGF)-VEGFRs, Angiopoietin-Tie, Ephrin-EphRs and Delta-Notch to be the major regulators of angiogenesis in vertebrates. VEGF and its receptors play a central role in physiological as well as pathological angiogenesis, and functional inhibitors of VEGF and VEGFRs such as anti-VEGF neutralizing antibody and small molecules that block the tyrosine kinase activity of VEGFRs have recently been approved for use to treat patients with colorectal, lung, renal and liver cancers. These drugs have opened a novel field of cancer therapy, i.e. anti-angiogenesis therapy. However, as yet they cannot completely cure patients, and cancer cells could become resistant to these drugs. Thus, it is important to understand further the molecular mechanisms underlying not only VEGF-VEGFR signaling but also the VEGF-independent regulation of angiogenesis, and to learn how to improve anti-angiogenesis therapy.
Similar articles
- Antiangiogenic therapies targeting the vascular endothelia growth factor signaling system.
Tie J, Desai J. Tie J, et al. Crit Rev Oncog. 2012;17(1):51-67. doi: 10.1615/critrevoncog.v17.i1.50. Crit Rev Oncog. 2012. PMID: 22471664 Review. - [VEGF, anti-vEGF and diseases].
Corvol P. Corvol P. Bull Acad Natl Med. 2008 Feb;192(2):289-300; discussion 300-2. Bull Acad Natl Med. 2008. PMID: 18819684 Review. French. - Vascular endothelial growth factor receptors: expression and function in solid tumors.
Wey JS, Stoeltzing O, Ellis LM. Wey JS, et al. Clin Adv Hematol Oncol. 2004 Jan;2(1):37-45. Clin Adv Hematol Oncol. 2004. PMID: 16163158 Review. - Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases.
Shibuya M. Shibuya M. J Biochem. 2013 Jan;153(1):13-9. doi: 10.1093/jb/mvs136. Epub 2012 Nov 21. J Biochem. 2013. PMID: 23172303 Free PMC article. Review. - Tumor angiogenesis and anti-angiogenic therapies.
Shahneh FZ, Baradaran B, Zamani F, Aghebati-Maleki L. Shahneh FZ, et al. Hum Antibodies. 2013;22(1-2):15-9. doi: 10.3233/HAB-130267. Hum Antibodies. 2013. PMID: 24284305 Review.
Cited by
- Exploring Current Molecular Targets in the Treatment of Neovascular Age-Related Macular Degeneration toward the Perspective of Long-Term Agents.
Fragiotta S, Bassis L, Abdolrahimzadeh B, Marino A, Sepe M, Abdolrahimzadeh S. Fragiotta S, et al. Int J Mol Sci. 2024 Apr 17;25(8):4433. doi: 10.3390/ijms25084433. Int J Mol Sci. 2024. PMID: 38674018 Free PMC article. Review. - SOX2 promotes vasculogenic mimicry by accelerating glycolysis via the lncRNA AC005392.2-GLUT1 axis in colorectal cancer.
Huang S, Wang X, Zhu Y, Wang Y, Chen J, Zheng H. Huang S, et al. Cell Death Dis. 2023 Dec 4;14(12):791. doi: 10.1038/s41419-023-06274-1. Cell Death Dis. 2023. PMID: 38044399 Free PMC article. - Spontaneous massive fetomaternal hemorrhage: two case reports and a literature review of placental pathology.
Zheng Y, Li D, Li X, Zheng A, Wang F. Zheng Y, et al. BMC Pregnancy Childbirth. 2023 Jul 21;23(1):530. doi: 10.1186/s12884-023-05826-9. BMC Pregnancy Childbirth. 2023. PMID: 37480031 Free PMC article. Review. - Research advances in drug therapy of endometriosis.
Shi J, Tan X, Feng G, Zhuo Y, Jiang Z, Banda S, Wang L, Zheng W, Chen L, Yu D, Guo C. Shi J, et al. Front Pharmacol. 2023 Jun 21;14:1199010. doi: 10.3389/fphar.2023.1199010. eCollection 2023. Front Pharmacol. 2023. PMID: 37416064 Free PMC article. Review. - Molecular Features, Prognostic Value, and Cancer Immune Interactions of Angiogenesis-Related Genes in Ovarian Cancer.
Ji Y, Ge Q, Zhang W, Qu P. Ji Y, et al. Reprod Sci. 2023 May;30(5):1637-1650. doi: 10.1007/s43032-022-01123-6. Epub 2022 Dec 5. Reprod Sci. 2023. PMID: 36471217
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous